Back
ImmunityBio, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
IBRX
ImmunityBio, Inc.
Last Price:
$7.29
Seasonality Move:
36.9%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and IBRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ImmunityBio, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.38 | Sell |
| 20-day SMA: | 8.01 | Sell |
| 50-day SMA: | 7.75 | Sell |
| 200-day SMA: | 3.83 | Buy |
| 8-day EMA: | 7.5 | Sell |
| 20-day EMA: | 7.86 | Sell |
| 50-day EMA: | 7.27 | Buy |
| 200-day EMA: | 4.73 | Buy |
ImmunityBio, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 46.2 | Sell |
| Chaikin Money Flow: | 11044509 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.43 - 9.25) | Sell |
| Bollinger Bands (100): | (2.2 - 8.02) | Buy |
ImmunityBio, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ImmunityBio, Inc. Stock
Is ImmunityBio, Inc. Stock a Buy?
-
ImmunityBio, Inc. share price is 7.30 while IBRX 8-day simple moving average is 7.38, which is a Sell signal.
-
The stock price of IBRX is 7.30 while ImmunityBio, Inc. 20-day SMA is 8.01, which makes it a Sell.
-
ImmunityBio, Inc. 50-day simple moving average is 7.75 while IBRX share price is 7.30, making it a Sell technically.
-
IBRX stock price is 7.30 and ImmunityBio, Inc. 200-day simple moving average is 3.83, creating a Buy signal.
IBRX Technical Analysis vs Fundamental Analysis
Sell
35
ImmunityBio, Inc. (IBRX)
is a Sell
Is ImmunityBio, Inc. a Buy or a Sell?
-
ImmunityBio, Inc. stock is rated a SellThe current ImmunityBio, Inc. [IBRX] share price is $7.30. The Score for IBRX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
ImmunityBio, Inc. Stock Info
Market Cap:
7.7B
Price in USD:
7.30
Share Volume:
14M
ImmunityBio, Inc. 52-Week Range
52-Week High:
12.43
52-Week Low:
1.83
Sell
35
ImmunityBio, Inc. (IBRX)
is a Sell
ImmunityBio, Inc. Share Price Forecast
-
What is the ImmunityBio, Inc. stock price today?The ImmunityBio, Inc. stock price is 7.30 USD today.
-
Will IBRX stock go up or go down?ImmunityBio, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is ImmunityBio, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ImmunityBio, Inc. is overvalued.
Is ImmunityBio, Inc. Stock a Buy?
-
ImmunityBio, Inc. share price is 7.30 while IBRX 8-day exponential moving average is 7.50, which is a Sell signal.
-
The stock price of IBRX is 7.30 while ImmunityBio, Inc. 20-day EMA is 7.86, which makes it a Sell.
-
ImmunityBio, Inc. 50-day exponential moving average is 7.27 while IBRX share price is 7.30, making it a Buy technically.
-
IBRX stock price is 7.30 and ImmunityBio, Inc. 200-day simple moving average is 4.73, creating a Buy signal.
Fundamental Analysis of ImmunityBio, Inc.
Is ImmunityBio, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.06 per share, an increase this year of $0.15 per share, and an increase next year of $0.23 per share.
Technical Analysis of ImmunityBio, Inc.
Should I short ImmunityBio, Inc. stock?
-
IBRX Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting ImmunityBio, Inc. is a Sell
-
ImmunityBio, Inc. Relative Strength Index (RSI) is 46.2, which suggest ImmunityBio, Inc. is oversold
-
The Bollinger Bands (25) for ImmunityBio, Inc. is (7.43 - 9.25), which suggest ImmunityBio, Inc. is a Buy
-
The Bollinger Bands (100) for ImmunityBio, Inc. is (2.2 - 8.02), which suggest ImmunityBio, Inc. is a Buy
* ImmunityBio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.